DR. Ruth Sylvia Horowitz, M.D. is an endocrinology and diabetes and metabolism internal medicine in Baltimore, MD with 36 years of experience. The provider is an internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems. DR. Ruth Sylvia Horowitz, M.D. NPI is 1003811423. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Graduation Year:1988
The provider's business location address is:
6535 N CHARLES ST
STE 400
BALTIMORE, MD
ZIP 21204-826
Phone: (410) 828-7417
Fax: (410) 828-0257
The NPI 1003811423 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Hemoglobin a1c level (HCPCS:83036)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Bone density measurement using dedicated x-ray machine (HCPCS:77080)
- Ultrasound of head and neck (HCPCS:76536)
- Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours (HCPCS:95251)
- Administration of influenza virus vaccine (HCPCS:G0008)
The enumeration date for this NPI number is 6/14/2005 and was last updated on 9/29/2017.